Clinical Trial Update: Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia [Phase 2]

View source ↗

Summary

Phase 2 trial comparing convalescent plasma to best available therapy for SARS-CoV-2 pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia
• Coronavirus Infection

Drugs mentioned

• Convalescent Plasma (convalescent plasma)

Snippet

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez | Conditions: Coronavirus Infection | Phase 2 | Status: COMPLETED